Donald Olds, Chief Operating Officer, Telesta Therapeutics Inc., Telephone: (514)-394-7921, Donald.Olds@telestatherapeutics.comCopyright CNW Group 2015
Telesta Therapeutics Corporate Update
View original source (CNW)Telesta Therapeutics Inc on 6ix
Earlier from Telesta Therapeutics
- Telesta Therapeutics Announces Results of the FDA Advisory Committee Vote
- Telesta Therapeutics Inc. Announces Results of Annual General Meeting of Shareholders
- Telesta Therapeutics Publishes its Q1, 2016 Financial Statements and Provides Corporate Updates
- Telesta Therapeutics and Ipsen announce exclusive license agreement for MCNA(1) for the treatment of non-muscle invasive bladder cancer in major ex-United States territories
- Telesta Therapeutics Appoints Brian J. Groch as Chief Commercial Officer
Later from Telesta Therapeutics
- Telesta Therapeutics Receives Complete Response Letter from FDA
- Telesta Therapeutics Publishes its Q2, 2016 Financial Statements and Provides Corporate Updates
- Telesta Therapeutics Provides Corporate Update
- Telesta Therapeutics Corporate Update - Type A Meeting with the FDA Scheduled
- Telesta Announces Type A Meeting Results and Strategic Option Review
Follow Telesta Therapeutics into a list and get an email when it puts out news.
Follow Telesta Therapeutics